🔎 Trials Near Me

Dachaigh › Diabaitis Seòrsa 2 › Connecticut

Sgrùdaidhean clionaigeach Diabaitis Seòrsa 2 ann an Connecticut

Tha 14 sgrùdaidhean airson Diabaitis Seòrsa 2 a’ lorg phàirtichean aig làraichean ann an Connecticut.

Bailtean ann an Connecticut

Teacsa sgrùdaidh oifigeil (Beurla)

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Chase Medical Research LLC, Waterbury
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
  • Cardiology Associates of Fairfield County, Stamford
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07064473

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • New England Research Associates, LLC, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07282600

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Yale University, New Haven
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Bridgeport
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07662213

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Yale School of Medicine, New Haven
A’ fastadhÌre 3
Aoisean 10 gu 18 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07282613

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Bridgeport
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07662044

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Yale Diabetes Research, New Haven
A’ fastadhÌre 3
Aoisean 10 gu 17 · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06739122

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Yale, New Haven
A’ fastadh
Aoisean 14 gu 75 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT07579702

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

  • Yale University, New Haven
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT07376655

Ultrasound Effects on Glycemic Control in T2DM

  • Yale-New Haven Hospital, New Haven
A’ fastadh
Aoisean 21 gu 75 · Gach gnè · Air ùrachadh 27 Faoi 2026 · NCT05354947

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

  • Fair Haven Community Health Care (FHCHC), New Haven
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Dùbh 2025 · NCT06658067

Diabetes Learning in Virtual Environments Just in Time for Community Reentry

  • University of Connecticut, Storrs
  • University of Connecticut, Storrs Mansfield
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2025 · NCT05286892

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

  • Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 14 Faoi 2025 · NCT05776563

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.